The Pulmonary Or Respiratory Drug Delivery Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The global market for pulmonary or respiratory drug delivery has seen robust growth lately. The market size escalated from $69.83 billion in 2024 and is projected to reach $76.38 billion in 2025, growing at a Compound Annual Growth Rate (CAGR) of 9.4%.
The Pulmonary Or Respiratory Drug Delivery Global Market Report 2025 forecasts that by 2029, the market will have grown to $107.85 billion, with a compound annual growth rate (CAGR) of 9.0%.
Download Your Free Sample of the 2025 Pulmonary Or Respiratory Drug Delivery Market Report and Uncover Key Trends Now!The key drivers in the pulmonary or respiratory drug delivery market are:
•Increasing demand for personalized medicine
•Rising prevalence of chronic respiratory diseases
•Growing focus on telemedicine
•Increased investments in healthcare infrastructure.
The pulmonary or respiratory drug delivery market covered in this report is segmented –
1) By Product: Formulation Type, Device Type
2) By Canister Type: Plain Canister, Coated Canister
3) By Application: Chronic Obstructive Pulmonary Disease, Asthma, Cystic Fibrosis, Other Applications
4) By End-User: Hospitals, Clinics, Home Care Settings
Subsegments:
1) By Formulation Type: Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs), Nebulizers, Liquid Aerosols, Nasal Sprays
2) By Device Type: Inhalers (Manual and Digital), Nebulizers (Compressor, Ultrasonic, Mesh), Breath-Activated Devices, Spacer Devices, Nasal Drug Delivery Devices
The key trends in the pulmonary or respiratory drug delivery market are:
•The adoption of new advancements in particle engineering is a prominent trend.
•There is ongoing development of advanced nebulizers in the market.
•Liposomal formulations are progressively gaining popularity.
•The market is witnessing the rise of computational fluid dynamics and smart inhalers.
Major players in the pulmonary or respiratory drug delivery market are:
• Merck & Co. Inc.
• Novartis AG
• Thermo Fisher Scientific Inc.
• AstraZeneca plc
• Abbott Laboratories
• 3M Company
• Koninklijke Philips N.V.
• GlaxoSmithKline
• Omron Corporation
• Teva Pharmaceutical Industries Ltd.
• Aptar Pharma
• Sumitomo Pharma America Inc.
• Chiesi Farmaceutici S.p.A.
• Cipla Inc.
• Boehringer Ingelheim GmbH
• Kindeva Drug Delivery Limited
• Nemera Group
• Hovione
• H And T Presspart Group
• Vectura Group plc
North America was the largest region in the pulmonary or respiratory drug delivery market in 2024